Ana sayfa
Piyasalar
Grafikler ve fikirler
Algo
Haberler
Store
Aracı kurumlar
İndir
Ekonomik Takvim
Alım-satım sinyalleri
Web Terminali
Arama yapmak için
/
tuşuna basın: @kullanıcı, $sembol, ...
Ara
Giriş yap
Hesap oluştur
Türkçe
English
Русский
中文
Español
Português
日本語
Deutsch
한국어
Français
Italiano
NVCT
#3038
Nuvectis Pharma, Inc. Common Stock
8.8
6
-0.78%
Sektör:
Baz:
Kar para birimi:
Günlük aralık
Yıllık aralık
Günlük değişim
-0.78%
Aylık değişim
+0.68%
6 aylık değişim
+32.24%
Yıllık değişim
+27.85%
Önceki kapanış
8.9
3
Open
8.8
6
Bid
Ask
Low
8.8
6
High
8.8
6
Hacim
17
Piyasalar
ABD hisse senetleri
Sağlık hizmetleri
NVCT
Open full chart
Financials
Overview
Rapor
Statistics
Dividends
Quarterly
Annual
Value
Q3, 24
Q4, 24
Q1, 25
Q2, 25
Q3, 25
Q4, 25
TTM
Key stats
Total common shares outstanding
19.32 M
23.39 M
23.63 M
25.46 M
25.61 M
26.49 M
—
Valuation ratios
Enterprise value
104.33 M
108.05 M
201.01 M
163.36 M
118.8 M
168.41 M
651.59 M
Price to earnings ratio
-5.42
-4.87
-8.65
-6.38
-4.39
-5.72
-25.14
Price to sales ratio
—
—
—
—
—
—
—
Price to cash flow ratio
7.59
7.56
14.55
11.48
8.49
10.29
44.81
Price to book ratio
2.09
9.53
3.26
2.45
1.74
8.94
16.39
Enterprise value to EBITDA ratio
—
—
—
—
—
—
—
Profitability ratios
Return on assets %
0.24
0.34
0.18
0.23
0.21
0.23
0.85
Return on equity %
0.38
0.64
0.25
0.38
0.31
0.4
1.34
Return on invested capital %
—
—
—
—
—
—
—
Gross margin %
—
—
—
—
—
—
—
Operating margin %
—
—
—
—
—
—
—
EBITDA margin %
—
—
—
—
—
—
—
Net margin %
—
—
—
—
—
—
—
Liquidity ratios
Quick ratio
—
—
—
—
—
—
—
Current ratio
2.74
2.09
3.28
2.66
3.07
2.38
11.4
Inventory turnover
—
—
—
—
—
—
—
Asset turnover
—
—
—
—
—
—
—
Solvency ratios
Debt to assets ratio
—
—
—
—
—
—
—
Debt to equity ratio
—
—
—
—
—
—
—
Long term debt to total assets ratio
—
—
—
—
—
—
—
Long term debt to total equity ratio
—
—
—
—
—
—
—
Per share metrics
Operating cash flow per share
0.14
0.14
0.21
0.16
0.2
0.18
0.75
EBIT per share
—
—
—
—
—
—
—
EBITDA per share
—
—
—
—
—
—
—
Total debt per share
—
—
—
—
—
—
—
Cash per share
1
1.08
1.5
1.25
1.56
1.45
5.76
Net current asset value per share
1
1.09
1.51
1.26
1.57
1.45
5.8
Tangible book value per share
0.64
0.57
1.05
0.79
1.06
0.84
3.74
Working capital per share
0.64
0.57
1.05
0.79
1.06
0.84
3.74
Book value per share
0.64
0.57
1.05
0.79
1.06
0.84
3.74
Haberler
Nuvectis, NXP900 ile osimertinib kombinasyonunu değerlendiren Faz 1b çalışmasını başlattı
Nuvectis initiates phase 1b trial combining NXP900 with osimertinib
H.C. Wainwright, Nuvectis Pharma için Al notunu yineledi
Nuvectis Pharma stock rating reiterated at Buy by H.C. Wainwright
Kaplan, Nuvectis Pharma (NVCT) hisselerinden 64.240 dolar değerinde satın aldı
Nuvectis Pharma başkanı Bentsur 28.600 dolarlık hisse alımı gerçekleştirdi
Nuvectis Pharma yöneticisi Sanchez, NVCT hisselerinden 75 bin dolarlık alım yaptı
H.C. Wainwright, Nuvectis Pharma hissesi için Al tavsiyesini 10 dolar hedefle yineledi
H.C. Wainwright reiterates Buy rating on Nuvectis Pharma stock at $10 target
Nuvectis Pharma adds former Intra-Cellular exec to board of directors
Nuvectis initiates phase 1b program for cancer drug NXP900
Nuvectis (NVCT) Q2 Loss Widens 43%